
Yorikast FX 4mg/60mg/50mg Tablet
Marketer
Bioris Pharmaceuticals
Salt Composition
Montelukast (4mg) + Fexofenadine (60mg) + Acebrophylline (50mg)
Overview Yorikast FX 4mg/60mg/50mg Tablet
Airmend Trio 4mg/60mg/50mg tablets combine medications to proactively manage asthma. This formulation alleviates allergy symptoms including nasal discharge, congestion, sneezing, lacrimation, and sinus pressure. It also facilitates bronchodilation, easing breathing by relaxing airway muscles. Airmend Trio is administered with or without food, as directed by your physician, in a dosage tailored to your individual needs and response. Continuous use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include nausea, emesis, abdominal discomfort, diarrhea, dermatitis, pruritus, dyspnea, and cephalalgia. Most are transient and self-limiting. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or tasks requiring alertness until the medicine's impact is known. Alcohol consumption should be avoided due to increased sedation risk. Prior to initiating treatment, disclose any renal or hepatic impairment to allow for appropriate dosage adjustment. Pregnancy, pregnancy planning, or breastfeeding should also be discussed with your doctor.
Uses of Yorikast FX 4mg/60mg/50mg Tablet
Respiratory distress characterized by bronchospasm.
Major Benefits of Yorikast FX 4mg/60mg/50mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Yorikast FX 4mg/60mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
Common Side effects of Yorikast FX 4mg/60mg/50mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Increased white blood cell count
- Increased transaminase level in blood
- Upper respiratory tract infection
- Constipation
- Abdominal discomfort
- Abdominal distension
- Heartburn
- Loss of appetite
- Esophageal bleeding
- Nasal inflammation
How to use Yorikast FX 4mg/60mg/50mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Yorikast FX 4mg/60mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
How Yorikast FX 4mg/60mg/50mg Tablet works:
Yorikast FX 4mg/60mg/50mg tablets contain Montelukast, Fexofenadine, and Acebrophylline, working synergistically to alleviate allergy symptoms. Montelukast, a leukotriene inhibitor, counteracts inflammatory responses by blocking leukotriene action in the respiratory and nasal passages. This, in turn, lessens allergy symptoms. Fexofenadine, an antihistamine, provides relief from common allergic manifestations such as nasal discharge, ocular itching, and sneezing. Acebrophylline, a mucolytic agent, facilitates the expectoration of mucus by reducing its viscosity.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Yorikast FX 4mg/60mg/50mg Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals may experience adverse effects from Yorikast FX 4mg/60mg/50mg tablets. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks versus benefits before prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Yorikast FX 4mg/60mg/50mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Yorikast FX 4mg/60mg/50mg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Yorikast FX 4mg/60mg/50mg tablets. Dosage modification for Yorikast FX 4mg/60mg/50mg tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Yorikast FX 4mg/60mg/50mg tablets in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but a physician's consultation is recommended.
What if you forget to take Yorikast FX 4mg/60mg/50mg Tablet :
Should you forget to take your Yorikast FX 4mg/60mg/50mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Yorikast FX 4mg/60mg/50mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
